Zobrazeno 1 - 10
of 1 828
pro vyhledávání: '"Halilovic, E."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pan RA; Bone Marrow Transplantation Center of the First Affiliated Hospital and Institute of Hematology and Department of Immunology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215., Wang Y; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Qiu S; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Villalobos-Ortiz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215., Morris E; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Halilovic E; Novartis Institute of Biomedical Research, Oncology Drug Discovery, Cambridge, MA 02139., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA ; Harvard Medical School, Boston, MA 02215. Anthony_Letai@dfci.harvard.edu.
Publikováno v:
Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1253-1258. Date of Electronic Publication: 2024 Apr 01.
Autor:
Hodzic E; Clinic for General and Abdominal Surgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Pusina S; Clinic for General and Abdominal Surgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Salibasic M; Clinic for General and Abdominal Surgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Rovcanin A; Clinic for General and Abdominal Surgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Halilovic E; Clinic for General and Abdominal Surgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Herenda N; Clinic for Anestesiology and Reanimatology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Publikováno v:
Medical archives (Sarajevo, Bosnia and Herzegovina) [Med Arch] 2024; Vol. 78 (1), pp. 29-32.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Decaudin D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France; Department of Medical Oncology, Institut Curie, Paris, France., Dit Leitz EF; Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Nemati F; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Tarin M; Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Naguez A; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Zerara M; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Marande B; Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Vivet-Noguer R; Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Halilovic E; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Fabre C; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Jochemsen A; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands., Roman-Roman S; Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France., Alsafadi S; Uveal Melanoma Translational Group, Department of Translational Research, Institut Curie, PSL Research University, Paris, France. Electronic address: samar.alsafadi@curie.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 May; Vol. 184, pp. 199. Date of Electronic Publication: 2023 Mar 01.
Autor:
Moujalled DM; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Brown FC; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Chua CC; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Dengler MA; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, Australia., Pomilio G; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Anstee NS; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Litalien V; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Thompson E; The University of Melbourne, Melbourne, Australia., Morley T; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., MacRaild S; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Tiong IS; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Department of Pathology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Morris R; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Dun K; Victorian Cancer and Cytogenetics Service, St. Vincent's Hospital, Melbourne, Fitzroy, Australia., Zordan A; Victorian Cancer and Cytogenetics Service, St. Vincent's Hospital, Melbourne, Fitzroy, Australia., Shah J; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia., Banquet S; Oncology Research and Development Unit, Institut de Recherches International Servier, Paris, France., Halilovic E; Novartis Institutes for BioMedical Research, Novartis, Cambridge, MA., Morris E; Novartis Institutes for BioMedical Research, Novartis, Cambridge, MA., Herold MJ; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, Australia., Lessene G; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, Australia., Adams JM; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, Australia., Huang DCS; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, Australia., Roberts AW; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Blombery P; The University of Melbourne, Melbourne, Australia., Wei AH; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred, Melbourne, Australia.; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; The University of Melbourne, Melbourne, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
Publikováno v:
Blood [Blood] 2023 Feb 09; Vol. 141 (6), pp. 634-644.
Autor:
Bauer S; Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Duisburg-Essen, Germany. sebastian.bauer@uk-essen.de., Demetri GD; Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, MA, USA., Halilovic E; Novartis Institutes for BioMedical Research (NIBR), Cambridge, MA, USA., Dummer R; University Hospital Zurich, Zurich, Switzerland., Meille C; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Tan DSW; National Cancer Center Singapore, Singapore, Singapore., Guerreiro N; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.; F. Hoffmann-La Roche AG, Basel, Switzerland., Jullion A; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Ferretti S; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Jeay S; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.; Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland., Van Bree L; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Hourcade-Potelleret F; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Wuerthner JU; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.; ADC Therapeutics, Epalinges, Switzerland., Fabre C; Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Aug; Vol. 125 (5), pp. 687-698. Date of Electronic Publication: 2021 Jun 17.